Bioorganic and Medicinal Chemistry Letters p. 2069 - 2072 (1996)
Update date:2022-08-05
Topics:
Kirkup, Michael P.
Rizvi, Razia
Shankar, Bandarpalle B.
Dugar, Sundeep
Clader, John W.
McCombie, Stuart W.
Lin, Sue-Ing
Yumibe, Nathan
Huie, Keith
Van Heek, Margaret
Compton, Douglas S.
Davis Jr., Harry R.
McPhail, Andrew T.
Previous SAR studies of C-3 side chain modified analogs of (-)-SCH 48461, as well as information concerning the metabolic stability this series, enabled us to design a cholesterol absorption inhibitor (i.e., (-) 2a, SCH 57939) with tenfold higher potency and greatly enhanced metabolic stability. The synthesis and pharmacological profile, including the role of relative stereochemistry at both the C3 and 1' positions in determining the SAR of these compounds, will be discussed.
View Morewebsite:http://www.sigmaaldrich.com
Contact:800 558-9160
Address:Industriestrasse 25CH-9471 Buchs SGSwitzerland
Contact:+86-371-86058576
Address:NO.32, Jingsan Road, Zhengzhou, China
Contact:+8618766299236
Address:ROOM808, BUILDING2,NO.230 SHEN ZHEN ROAD, LAOSHAN DISTRICT
Sichuan Highlight Fine Chemicals Co., Ltd.
Contact:+86-28-8525 1605
Address:A5-102 Airport base,388 West Airport Huang He Zhong Lu,2 Section
Dayang Chem (Hangzhou) Co.,Ltd.
website:http://www.dycnchem.com
Contact:+86-571-88938639
Address:9/F, Unit 2 Changdi Torch Building, 259# WenSan Road, Xihu District, Hangzhou City 310012, P.R.China
Doi:10.1002/psc.3148
(2019)Doi:10.1080/00945719809351659
(1998)Doi:10.1021/ja01006a029
(1968)Doi:10.1007/s11426-015-5368-z
(2015)Doi:10.1016/S0040-4039(02)02150-0
(2002)Doi:10.1016/j.bmcl.2005.09.004
(2006)
